RESUMEN
Congenital disorders of glycosylation (CDG) are genetic diseases characterized by deficient synthesis (CDG type I) and/or abnormal processing (CDG type II) of glycan moieties linked to protein and lipids. The impact of the molecular defects on protein glycosylation and in turn on the clinical phenotypes of patients with CDG is not yet understood. ALG12-CDG is due to deficiency of ALG12 α1,6-mannosyltransferase that adds the eighth mannose residue on the dolichol-PP-oligosaccharide precursor in the endoplasmic reticulum. ALG12-CDG is a severe multisystem disease associated with low to deficient serum immunoglobulins and recurrent infections. We thoroughly investigated the glycophenotype in a patient with novel ALG12 variants and immunodeficiency. We analyzed serum native transferrin, as first line test for CDG and we profiled serum IgG and total serum N-glycans by a combination of consolidated (N-glycan analysis by MALDI MS) and innovative mass spectrometry-based protocols, such as GlycoWorks RapiFluor N-glycan analysis coupled with LC-ESI MS. Intact serum transferrin showed, as expected for a CDG type I defect, underoccupancy of N-glycosylation sites. Surprisingly, total serum proteins and IgG N-glycans showed some specific changes, consisting in accumulating amounts of definite high-mannose and hybrid structures. As a whole, ALG12-CDG behaves as a dual CDG (CDG-I and II defects) and it is associated with distinct, abnormal glycosylation of total serum and IgG N-glycans. Glycan profiling of target glycoproteins may endorse the molecular defect unraveling the complex clinical phenotype of CDG patients.
Asunto(s)
Trastornos Congénitos de Glicosilación/genética , Deficiencia de IgG/genética , Inmunoglobulinas/genética , Manosiltransferasas/genética , Niño , Preescolar , Trastornos Congénitos de Glicosilación/sangre , Trastornos Congénitos de Glicosilación/patología , Retículo Endoplásmico/genética , Retículo Endoplásmico/metabolismo , Femenino , Glicoproteínas/sangre , Glicosilación , Humanos , Deficiencia de IgG/sangre , Deficiencia de IgG/metabolismo , Deficiencia de IgG/patología , Inmunoglobulinas/sangre , Inmunoglobulinas/deficiencia , Lactante , Masculino , Manosiltransferasas/sangre , Oligosacáridos/genética , Oligosacáridos/metabolismo , Polisacáridos/genética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Transferrina/genética , Transferrina/metabolismo , Secuenciación del ExomaRESUMEN
Aging has a strong impact on the activity of the immune system, enhancing susceptibility to pathogens and provoking a predominant pre-inflammatory status, whereas dampening responses to vaccines in humans and mice. Here, we demonstrate a loss of marginal zone B lymphocytes (MZ, CD19+CD45R+CD21++CD23lo) and a decrease of naive B cells (CD19+IgD+), whereas there is an enhancement of a CD19+CD45Rlo innate-like B cell population (B1REL) and the so-called aged B cell compartment (ABC, CD45R+CD21loCD23loCD5-CD11b-) in aged senescence-accelerated (SAMP8) mice but not in aged senescence-resistant (SAMR1) mice. These changes in aged SAMP8 mice were associated with lower IgG isotype levels, displaying low variable gene usage repertoires of the immunoglobulin heavy chain (VH) diversity, with a diminution on IgG1-memory B cells (CD11b-Gr1-CD138-IgM-IgD-CD19+CD38+IgG1+), an increase in T follicular helper (TFH, CD4+CXCR5+PD1+) cell numbers, and an altered MOMA-1 (metallophilic macrophages) band in primary follicles. LPS-mediated IgG1 responses were impaired in the B1REL and ABC cell compartments, both in vitro and in vivo. These data demonstrate the prominent changes to different B cell populations and in structural follicle organization that occur upon aging in SAMP8 mice. These novel results raise new questions regarding the importance of the cellular distribution in the B cell layers, and their effector functions needed to mount a coordinated and effective humoral response.
Asunto(s)
Envejecimiento/inmunología , Linfocitos B/inmunología , Deficiencia de IgG/genética , Inmunoglobulina G/genética , Bazo/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Envejecimiento/genética , Animales , Antígenos CD/genética , Antígenos CD/inmunología , Linfocitos B/efectos de los fármacos , Linfocitos B/patología , Muerte Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica , Deficiencia de IgG/metabolismo , Deficiencia de IgG/patología , Inmunidad Humoral , Inmunidad Innata , Inmunoglobulina D/genética , Inmunoglobulina D/metabolismo , Inmunoglobulina G/metabolismo , Cadenas Pesadas de Inmunoglobulina , Inmunoglobulina M/genética , Inmunoglobulina M/metabolismo , Memoria Inmunológica , Lipopolisacáridos/farmacología , Ratones Endogámicos C57BL , Ratones Transgénicos , Cultivo Primario de Células , Transducción de Señal , Bazo/citología , Bazo/efectos de los fármacos , Linfocitos T Colaboradores-Inductores/citología , Linfocitos T Colaboradores-Inductores/efectos de los fármacosRESUMEN
BACKGROUND: The severity of the 2009 pandemic H1N1 influenza (H1N1 pdm 09) in immune deficient children is unknown. The aim of the present study was to investigate this in a case of complete IgG3 deficiency complicated by pneumonia and asthma attack. METHODS: The clinical parameters of the IgG3 deficiency patient were compared with those of four control patients using 95% confidence intervals. These control patients were selected from 71 patients admitted due to pneumonia or bronchitis caused by H1N1 pdm 09, and were chosen according to age, absence of pretreatment with oseltamivir before admission, presence of a past history of asthma, use of antibiotics, and combination of inhalation of a beta2 agonist and treatment with i.v. methylprednisolone for asthma attack. RESULTS: The IgG3 deficiency patient had significantly longer duration of admission and period of oseltamivir, with a significantly decreased pulse oxygen saturation and increased maximum serum C-reactive protein, creatine kinase and urinary excretion of ß2-microglobulin/creatinine, compared with the controls (P < 0.05). CONCLUSIONS: Complete IgG3 deficiency is possibly associated with severity of the clinical course of pneumonia and asthma attack in children suffering from H1N1 pdm 09.
Asunto(s)
Asma/etiología , Deficiencia de IgG/complicaciones , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/epidemiología , Pandemias , Neumonía Viral/etiología , Adolescente , Asma/epidemiología , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Deficiencia de IgG/epidemiología , Deficiencia de IgG/metabolismo , Incidencia , Gripe Humana/complicaciones , Gripe Humana/diagnóstico , Japón/epidemiología , Masculino , Neumonía Viral/epidemiología , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Tasa de Supervivencia/tendenciasRESUMEN
Adequate surface protection of the upper airway tract depends on intimate co-operation between natural non specific defence mechanisms such as ciliary function and acquired adaptative immunity. The latter is mediated by specific antibodies mainly belonging to secretory immunoglobulin A (SIgA) and to lesser extent secretory IgM (SigM) as well as by serum derived and locally produced IgG. Immunoglobulin's deficiency may exist in a significant percentage of patients with chronic or recurrent infections of the upper respiratory tract. So an immunologic screening should be extended to patients who have persistent sinus infection, despite normal mucocilary and ventilation patterns, inadequate response to antimicrobial therapy, culture of unusual pathogens from the upper respiratory tract or history of infection at other side, mainly bronchopulmonary. The therapeutic aspects include immunoglobulin replacement or mucosal immunogens whose efficacy is related with both an unspecific and a specific way. In the future, cytokines will probably become the strongest therapy of the immunoglobulin's deficiency.